Q24. Drug therapy for initial treatment of metabolic syndrome is targeted at controlling which condition(s)? (Select all that apply.)

Q22. A patient is taking an HMG-CoA reductase inhibitor (statin) and reports muscle aches, soreness, and weakness. The nurse suspects these symptoms to indicate early signs of myopathy. When notifying the physician of these symptoms, the nurse will also be sure to report the results of the patient’s:

Q28. One of the medications used in Metabolic Syndrome therapy to target Type II Diabetes Mellitus is Metformin. What is the mechanism of action of metformin?        

Q25. The order reads, “Give enalapril 5 mg IV push over 5 minutes now.” The medication is available in a vial with the strength of 1.25 mg/mL. How many milliliters will the nurse administer for this dose?

Q1. The nurse reviews lipoproteins while educating a patient diagnosed with dyslipidemia. The nurse explains that there is one type that is referred to as the “good” lipoprotein because high levels indicate that cholesterol is being removed from vascular tissue. Which lipoprotein is the nurse describing?

Q3. Which drug class is used in treating dyslipidemia with the goal to lower the triglycerides and LDL cholesterol and raise the HDL cholesterol?

Why did I describe the Three-Fifths Compromise as evil during lecture?

How did the Articles of Confederation’s approach to interstate commerce and taxation lead to its failure?

18.  Attorney is a well-known criminal defense lawyer.  Attorney is representing two defendants (Defendant A and Defendant B) in the same drug case.  Each defendant is charged with trafficking cocaine, and Attorney believes he can represent both defendants’ interests.  Defendant A has two prior drug convictions, while Defendant B has a clean record.  Can Attorney represent both defendants?

15. Burke is one of two partners in the five-attorney firm of Burke & Quirk.  Burke represents J&J Corp. in a trademark infringement against JNJ Corp.  Burke interviews a former JNJ Corp. employee, Donald, who told him that the Board of Directors of JNJ Corp. knew how similar the name JNJ Corp. would be to J&J Corp., but wanted to use that to help market its baby products in stores.  One week after the interview, Donald dies.  In initial disclosures, Burke lists Donald as a witness.  Since Donald died, JNJ Corp.’s counsel goes to court to obtain Burke’s notes on his interview with Donald.  How should the court rule?